A paediatric toxicology laboratory differs from the adult equivalent in several key areas. Unlike adult poisonings, poisoning in children is mainly accidental. Single tablet ingestions are common, particularly in infants and young children. These can, however, produce symptoms and signs compatible with drug overdose or even result in fatalities. In an age group where language Skills are generally lacking, ingestions invariably present without a reliable drug history. In these instances, a complete drug screen rather than testing for specific drugs or drug groups is mandatory. Poisoning in children can often go unrecognized whilst more invasive tests are carried out, suspicions only being aroused when there is no obvious pathological explanation. This can result in considerable delay in the collection of specimens for 'emergency' toxicology.
We felt that these differences required modifications to be made if our paediatric toxicology laboratory was to include the commercially available thin layer chromatography (TLC) kit system, Toxi-Lab (Analytical Systems Inc, Laguna Hills, CA, USA) into an integrated scheme for drug and poison detection. Toxi-Lab is capable of detecting most drugs and metabolites in urine following the ingestion of therapeutic or overdose quantities.' Whilst optimum results require regular use of the system to gain familiarity with metabolite and artefactual patterns, by its very nature it reduces the requirement for high levels of expertise and is much less difficult than classic TLC, which is highly subjective. However, unlike classic TLC wherein a large volume (25-50 mL) of urine can be extracted and applied to the plate, the standard Toxi-Lab procedure allows a maximum of Correspondence: Dr N R Badcock. only 5 mL of specimen to be extracted. As a consequence, the parent drug is frequently not observed and sensitivity can be low, with a limit of detection of 5/Lg/mL for several drugs.' Enzyme hydrolysis increases yield but causes an unacceptable increase in artefactual spots.
These inherent limitations are further exacerbated by the differences in paediatric and adult toxicology and further restrict the use of Toxi-Lab in paediatric settings. If the exposure substance is already substantially excreted because the urine collection is delayed or if the limit of detection is too high for sufficient sensitivity, drugs eliminated from the body relatively rapidly as well as single tablet ingestions will probably pass unrecognized. False negatives can carry grave medical consequences.
We describe our adaptation of the recommended Toxi-Lab procedure, which not only permits the essential convenience of Toxi-Lab to be retained, but complements the system through the incorporation of ultraviolet spectrophotometry. It is employed, side by side, with urinary Emit-sr" tests (Syva Corp, Palo Alto, CA, USA), with the benzodiazepine modification-and several direct tests,' as initial techniques in a systematic toxicological scheme. As many more substances are detected with Toxi-Lab A (a broad spectrum of basic, neutral and some acidic drugs) than with Toxi-Lab B (barbiturates and some neutral drugs), the modification is only outlined for the former; however an analogous adaption is equally appropriate for Toxi-Lab B.
METHODS
To 25-50 mL of urine, sufficient dilute ammonium hydroxide solution is added to adjust the pH to 8. The urine is then extracted with twice its volume of spectroscopic grade diethyl ether, which has been rendered peroxide free. Following a water wash, the ether is extracted with 5 mL of O' 5 mollL hydrochloric acid, which is then separated and examined by ultraviolet spectrophotometry from 220 to 350 nm. The hydrochloric acid fraction containing basic drugs is made alkaline with sodium bicarbonate and transferred to a Toxi-tube A for back extraction and subsequent chromatography. A standard extraction, concentration and inoculation of 5 mL urine is performed in the second of the available channels on the chromatogram. Apart from our previously described modification of thoroughly drying the chromatogram after Stage III for enhanced theophylline detection," the four-stage detection sequence proceeds according to the manufacturer's instructions. The R F of the parent drug, the pattern of metabolites and colour changes through the four detection stages are then noted with the appropriate coloured pencils.
To validate the proposed changes, we assayed eighteen 24 h urine specimens collected from six adult volunteers who had been given, at 2-week intervals, 2 mg of haloperidol, benztropine, and thiothixene, using both standard Toxi-Lab and the modification with 50 mL of urine. We also assayed, again using both procedures, some 50 urine specimens, previously found to contain at least one basic drug on Toxi-Lab A and assessed, from spot diameter, the relative sensitivity of each procedure.
RESULTS
In all 18 extracts of the 'volunteer collections', the standard Toxi-Lab procedure failed to detect the presence of either the three parent drugs or their metabolites. However, when the same specimens were subjected to the modified procedure, both metabolites and the parent drugs, haloperidol, benztropine and thiothixene, were clearly visible on the chromatograms. Comparison of the test results indicated that detection was enhanced between four-fold and lO-fold by the modified procedure, presumably due to extracting from a much larger sample, as well as producing a much cleaner extract for subsequent chromatography.
DISCUSSION
By effectively condensing the volume of biological specimen from 25-50 mL down to 5 mL, the modification has enabled drug detection and identification from many single-tablet ingestions, and from ingestions at therapeutic dosage where the drug is rarely detected in urine using the Ann Clin Biochem 1996: 33 standard Toxi-Lab procedure. The modified procedure allows visualization of the parent drug as well as metabolite, reduction of background interference and verification of poisoning several days after drug ingestion. Collection of 25-50 mL of urine, even from very young children, has rarely proved a problem in our experience.
Chromatography of the back extract which contains the basic fraction only, in parallel with the disc on which the neutral, basic and some acidic drugs are concentrated, also provides very useful information on drug type. For example, methaqualone, meprobamate and spironolactone are neutral drugs, which are not extracted into hydrochloric acid and appear only in track two.
Diethyl ether is recommended for the extraction, since it is less toxic than halogenated hydrocarbons, which can also degrade drugs having tertiary amine groups. Further, emulsions are rarely formed compared to other extraction methods and separation of the drugs is accomplished in a relatively short time. The ether used must be peroxide-free, and spectroscopic grade ether is shaken with freshly prepared ferrous sulphate solution immediately before use to remove any residual peroxide.
The use of the non-destructive ultraviolet spectrophotometric procedure provides confirmatory evidence for the identity of many basic drugs. While it is insensitive for the few drugs which have low extinction coefficients, and (unlike the subsequent chromatography) will not readily resolve mixtures having similar ultraviolet spectra, for the vast majority of compounds absorption spectra can yield a great deal of information in a relativelyshort time. Importantly, it also allows identification of several drugs not included in the Toxi-Lab compendium, such as oxybutynin, lamotrigine, mefloquine and moclobemide. For example, within 5-10 min of receiving a urine specimen containing mefloquine, an ultraviolet spectrum will permit identification of the drug from its three distinct absorption maxima at 222, 304 and 317 nm. In our laboratory, ultraviolet spectral data used for comparison and identification purposes is recorded from either the pure substance, a urine extract of a known proven drug ingestion or various literature sources.t-"
. In summary, the modified method has proved to be an invaluable addition to our routine drug screening procedures since it combines the intrinsic advantages of an ultraviolet spectrum with a much cleaner, more concentrated specimen for subsequent chromatography and separates basic drugs from other interfering fractions including artefacts. It was developed for routine use in our hospital toxicology laboratory after several unsuccessful attempts at identifying ingestions in young children using Toxi-Lab according to the manufacturer's instructions. Combined with other simple tests to detect poisoning, it provides a useful procedure for a first line screening protocol and confirmation of positive findings in emergency toxicology.
